1.22000 EUR
0
0%
Last update Dec 12, 1:00 AM CET
Main market
Day range
1.22000
1.22000
Previous close
1.22000
Open
1.22000
Access this stock data via API
Subscribe
NRX Pharmaceuticals Inc.
1.22
0
0%

Financials

Income statement

Fundamentals currency is USD
Fiscal date Sep 2025 Jun 2025 Mar 2025 Dec 2024
Total reported revenue 206.2K 0 0 0
Cost of revenue 82.7K
Gross profit 123.6K
Operating expense
Research & development 1.2M 841.2K 685.2K 882.9K
Selling general and admin 2.4M 2.3M 2.5M 2.2M
Other operating expenses -80.1K
Operating income -3.4M -3.2M -3.2M -2.1M
Non operating interest income
Income 1.7K 1.7K 3.4K 3.4K
Expense 0 0 0 0
Other income expense -1.6M -11.8M -1.5M -5.7M
Pretax income -5.0M -15.0M -4.7M -7.7M
Tax provision
Net income -5.0M -15.0M -4.7M -7.7M
Basic EPS -0.3 -1.0 -0.3
Diluted EPS -0.3 -1.0 -0.3
Basic average shares 18.9M 15.3M 14.0M
Diluted average shares 18.9M 15.3M 14.0M
EBITDA -4.7M -9.5M -6.0M -6.3M
Net income from continuing op. -5.0M -15.0M -4.7M -7.7M
Minority interests
Preferred stock dividends
Access the full /income_statement historical dataset via the API — starting from the Pro plan.
Main market

Exchange is currently active.
Closing in 8 hours

11:59
00:00
08:00
20:00
23:59

Trading Hours (Monday - Friday):

Main market
08:00 - 20:00
All times are displayed in the Europe/Berlin timezone (CET, UTC+01:00).